NK

Naresh Kamalakar Patil

Active Director Director DIN 09061123
DIN 09061123 First appointment Feb 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Naresh Kamalakar Patil

Data last updated:

Naresh Kamalakar Patil is a Director at Cynodon Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09061123
Primary Designation Director
Industry Chemicals
First Appointment 09 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Feb 20212021Active

Board colleagues of Naresh Kamalakar Patil

Directorship timeline

Open interactive timeline →
Cynodon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Naresh Kamalakar Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Kamalakar Patil

Naresh Kamalakar Patil currently holds 1 directorship: Cynodon Pharmaceuticals Private Limited (Director, since 09 Feb 2021).

Naresh Kamalakar Patil was first appointed on 09 Feb 2021 as Director at Cynodon Pharmaceuticals Private Limited.

The current boards of Naresh Kamalakar Patil's companies include Abhay Ravindranath Patil (Cynodon Pharmaceuticals Private Limited), Sarika Girish Patil (Cynodon Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available